Zotefoams plc
(the 'Company')
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
30 May 2024 - The Company announces that it has received notification by certain Directors and Persons Discharging Managerial Responsibilities (PDMR) of transactions in ordinary shares of 5 pence each in the Company ('Ordinary Shares'), as detailed below.
|
|
Name |
Nature of transaction |
Number of Ordinary Shares |
Price per Ordinary Share |
Date of transaction |
|
Director |
G C McGrath* |
Sale of Ordinary shares |
10,000 |
£5.43 |
28 May 2024 |
|
Purchase of Ordinary Shares |
9,696 |
£5.60 |
30 May 2024 |
||
|
PDMR |
H Morgan |
Sale of Ordinary Shares |
10,000 |
£5.42 |
29 May 2024 |
|
K D Hewson** |
Exercise and sale of Ordinary Shares under the Approved Share Option Plan |
5,263 |
£5.44 |
28 May 2024 |
|
|
N Court-Johnston** |
Exercise and sale of Ordinary Shares under the Approved Share Option Plan |
3,468 |
£5.44 |
28 May 2024 |
* G C McGrath, Group CFO, effected a transfer of shares between his personal holding and ISA accounts. On 28 May 2024, G C McGrath sold a total of 10,000 Ordinary Shares from his personal holding and subsequently purchased, on 30 May 2024, in aggregate, 9,696 Ordinary Shares into his ISA account. Following these transactions, G C McGrath's beneficial interest has moved slightly as a result of share price movements over period between sale and repurchase, and stands at 102,196 Ordinary Shares, representing approximately 0.21% of the Company's issued share capital.
** On 28 May 2024, the Company received notice from its Employee Benefit Trust of the exercise of these options granted over Ordinary Shares under the Company's Approved Share Option.
The Notification of Dealing Form can be found below.
This announcement is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
Lydia Harratt
Group Company Secretary
Zotefoams plc
020 8664 1600
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA and Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).
AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||
|
a) |
Name: Gary Christopher McGrath |
|||||||||
2. |
Reason for the notification |
|||||||||
|
a) |
Position/status: Group CFO |
|||||||||
|
b) |
Initial notification/Amendment: Initial notification |
|||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
|
a) |
Name: Zotefoams plc |
|||||||||
|
b) |
LEI: 213800B6P256B5XN8D32 |
|||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
|||||||||
|
b) |
Nature of the transaction: 1. Sale of 10,000 Ordinary Shares by G C McGrath 2. Purchase of 9,696 Ordinary Shares into G C McGrath's ISA account |
|||||||||
|
c) |
Price(s) and volume(s):
|
|||||||||
|
d) |
Aggregated information: n/a - each a single transaction |
|||||||||
|
e) |
Date of the transaction: 1. 28 May 2024 2. 30 May 2024 |
|||||||||
|
f) |
Place of the transaction: XLON |
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||
|
a) |
Name: Hugh de Riemer Morgan |
||||
2. |
Reason for the notification |
||||
|
a) |
Position/status: Senior Executive |
||||
|
b) |
Initial notification/Amendment: Initial notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name: Zotefoams plc |
||||
|
b) |
LEI: 213800B6P256B5XN8D32 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||
|
b) |
Nature of the transaction: Sale of Ordinary Shares |
||||
|
c) |
Price(s) and volume(s):
|
||||
|
d) |
Aggregated information: n/a |
||||
|
e) |
Date of the transaction: 29 May 2024 |
||||
|
f) |
Place of the transaction: XLON |
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||
|
a) |
Name: Karl David Hewson |
||||
2. |
Reason for the notification |
||||
|
a) |
Position/status: Senior Executive |
||||
|
b) |
Initial notification/Amendment: Initial notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name: Zotefoams plc |
||||
|
b) |
LEI: 213800B6P256B5XN8D32 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||
|
b) |
Nature of the transaction: Exercise and sale of Ordinary Shares under the Approved Share Option Plan |
||||
|
c) |
Price(s) and volume(s):
|
||||
|
d) |
Aggregated information: n/a |
||||
|
e) |
Date of the transaction: 28 May 2024 |
||||
|
f) |
Place of the transaction: XLON |
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||
|
a) |
Name: Neil Court-Johnston |
||||
2. |
Reason for the notification |
||||
|
a) |
Position/status: Senior Executive |
||||
|
b) |
Initial notification/Amendment: Initial notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name: Zotefoams plc |
||||
|
b) |
LEI: 213800B6P256B5XN8D32 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||
|
b) |
Nature of the transaction: Exercise and sale of Ordinary Shares under the Approved Share Option Plan |
||||
|
c) |
Price(s) and volume(s):
|
||||
|
d) |
Aggregated information: n/a |
||||
|
e) |
Date of the transaction: 28 May 2024 |
||||
|
f) |
Place of the transaction: XLON |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
